美国人口普查部门间肝细胞癌发病率趋势的差异,2001年至2021年
Itunu O Sokale1,2, Omar Rosales1, Aaron P Thrift1,2
1Section of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
Cancers
|May 14, 2025
概括
肝细胞癌 (HCC) 发病率在全国范围内增加,但最近下降,具有显著的地理和种族差异. 有针对性的干预措施至关重要,以解决美国人口普查部门中HCC率的差异.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 肝细胞癌 (HCC) 是美国癌症死亡的主要原因.
- 了解HCC发病率的国家和地区趋势对于公共卫生倡议至关重要.
研究的目的:
- 提供对HCC发病率的国家世俗趋势的最新分析.
- 调查美国人口普查部门中HCC发病率的地理和种族/种族差异.
主要方法:
- 来自美国癌症统计数据库 (USCS) 的HCC发病率数据 (2001-2021年,不包括2020年) 的分析.
- 根据年龄调整的发病率使用国家癌症研究所的关节点回归计划进行了分析.
- 趋势是根据美国人口普查部门在全国范围内检查的,并按种族/种族分层.
主要成果:
- 国家HCC发病率从2001-2021年平均每年增加2.51%,但最近下降了-3.33% (2018-2021).
- 观察到区域差异很大,第1部门的下降幅度最大,第6和第7部门的下降率稳定.
- 最近的趋势表明,非西班牙裔黑人和亚洲/太平洋岛民人口大幅减少,其他群体的趋势不同.
结论:
- 全国HCC发病率正在下降,但这些趋势在所有美国人口普查部门或种族/种族群体中并不统一.
- 在不同人群中,HCC发病率仍然存在显著差异.
- 需要针对种族的公共卫生干预措施,以减少全国范围内的HCC发病率差异.
更多相关视频
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
1.1K
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.7K
相关概念视频
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Applications of Life Tables
38
Life tables are versatile across various fields, providing a quantitative basis for analyzing mortality and survival rates. Whether used by demographers, actuaries, epidemiologists, or sociologists, life tables offer valuable insights into the dynamics of life and death, facilitating informed decisions in public health, insurance, conservation, and beyond. Their broad applicability highlights the interconnectedness of demographic data with practical outcomes in everyday life and strategic...
38
Cancer
47.2K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
47.2K
Cancer Survival Analysis
311
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
311
